The global C-reactive protein (CRP) testing market is anticipated to witness steady growth from 2025 to 2033, driven by the rising prevalence of chronic inflammatory diseases, infections, and cardiovascular conditions. The market is expected to be valued at USD 3.1 billion in 2025 and projected to reach USD 5.8 billion by 2033, growing at a CAGR of 8.2% during the forecast period.